Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

NCT07725380 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma
Osteosarcoma

Interventions

DRUG: Domatinostat
DRUG: Sirolimus

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]